Skip to main content
. 2010 Mar;24(3):197–201. doi: 10.1155/2010/846353

TABLE 2.

Endoscopic and histological inflammation scores pre- and post-treatment

Inflammation Group A (observation)
Group B (rabeprazole)
Group C (hydrotalcite)
Group D (combination)
Pre Post P Pre Post P Pre Post P Pre Post P
Endoscopic scores
  Hyperemia 2.25±0.74 2.18±0.81 0.053 2.13±0.87 2.15±0.79 0.083 2.20±0.85 2.16±0.77 0.069 2.18±0.69 2.00±0.80 0.102
  Edema 2.10±0.75 2.09±0.64 0.071 2.09±0.63 1.99±0.73 0.051 2.13±0.81 2.01±0.78 0.052 2.11±0.77 1.50±0.67 0.027*
Histological scores
  Chronic inflammation 3.54±0.70 3.55±0.65 0.062 3.40±0.79 3.65±0.46 0.091 3.29±0.81 3.31±0.79 0.421 3.31±0.76 3.47±0.66 0.054
  Activity 2.90±0.72 2.57±0.85 0.077 2.95±0.68 2.76±0.91 0.060 2.45±0.54 2.50±0.47 0.051 2.87±0.72 1.97±0.78 0.029*

Pre- and post-treatment data presented as mean ± SD. Scores of chronic inflammation and activity were graded on mononuclear cells and polymorphonuclear infiltration, respectively (0 = normal, 1 = mild, 2 = moderate and 3 = severe).

*

P<0.05 compared pre- and post-treatment in each group